Superior Tissue Evolution in Slow-Degrading Scaffolds for Valvular Tissue Engineering.
暂无分享,去创建一个
F. Baaijens | C. Bouten | A. Driessen-Mol | C. Bouten | M. Brugmans | M. Cox | D. van Geemen | R. S. Soekhradj-Soechit | Frank P.T. Baaijens
[1] F. Baaijens,et al. Poly‐ε‐caprolactone scaffold and reduced in vitro cell culture: beneficial effect on compaction and improved valvular tissue formation , 2015, Journal of tissue engineering and regenerative medicine.
[2] Simon P. Hoerstrup,et al. Bioresorbable Scaffolds for Cardiovascular Tissue Engineering , 2014, EMJ Interventional Cardiology.
[3] Benedikt Weber,et al. Transcatheter implantation of homologous "off-the-shelf" tissue-engineered heart valves with self-repair capacity: long-term functionality and rapid in vivo remodeling in sheep. , 2014, Journal of the American College of Cardiology.
[4] J. Humphrey,et al. Beyond burst pressure: initial evaluation of the natural history of the biaxial mechanical properties of tissue-engineered vascular grafts in the venous circulation using a murine model. , 2014, Tissue engineering. Part A.
[5] Martin Schweiger,et al. Off-the-shelf human decellularized tissue-engineered heart valves in a non-human primate model. , 2013, Biomaterials.
[6] Robert T. Tranquillo,et al. Tubular Heart Valves from Decellularized Engineered Tissue , 2013, Annals of Biomedical Engineering.
[7] Doris A Taylor,et al. Decellularized tissue-engineered heart valve leaflets with recellularization potential. , 2013, Tissue engineering. Part A.
[8] T. Schmitz-Rode,et al. Non-Destructive Analysis of Extracellular Matrix Development in Cardiovascular Tissue-Engineered Constructs , 2013, Annals of Biomedical Engineering.
[9] V. Falk,et al. Functionality, growth and accelerated aging of tissue engineered living autologous vascular grafts. , 2012, Biomaterials.
[10] G. Thouas,et al. Progress and challenges in biomaterials used for bone tissue engineering: bioactive glasses and elastomeric composites , 2012, Progress in Biomaterials.
[11] Frank P T Baaijens,et al. Decellularized homologous tissue-engineered heart valves as off-the-shelf alternatives to xeno- and homografts. , 2012, Biomaterials.
[12] Thomas Gilliland,et al. Tissue-engineered vascular grafts for use in the treatment of congenital heart disease: from the bench to the clinic and back again. , 2012, Regenerative medicine.
[13] C. Oomens,et al. Passive and active contributions to generated force and retraction in heart valve tissue engineering , 2012, Biomechanics and modeling in mechanobiology.
[14] van D Daphne Geemen. Tissue properties and collagen remodeling in heart valve tissue engineering , 2012 .
[15] R. Gurny,et al. Long term performance of polycaprolactone vascular grafts in a rat abdominal aorta replacement model. , 2012, Biomaterials.
[16] Benedikt Weber,et al. Injectable living marrow stromal cell-based autologous tissue engineered heart valves: first experiences with a one-step intervention in primates. , 2011, European heart journal.
[17] Misty J. Williams-Fritze,et al. Characterization of the Natural History of Extracellular Matrix Production in Tissue-Engineered Vascular Grafts during Neovessel Formation , 2011, Cells Tissues Organs.
[18] Swee Hin Teoh,et al. Evaluation of polycaprolactone scaffold degradation for 6 months in vitro and in vivo. , 2009, Journal of biomedical materials research. Part A.
[19] Casey K. Chan,et al. Degradation behaviors of electrospun resorbable polyester nanofibers. , 2009, Tissue engineering. Part B, Reviews.
[20] Marcel C M Rutten,et al. Dynamic straining combined with fibrin gel cell seeding improves strength of tissue-engineered small-diameter vascular grafts. , 2009, Tissue engineering. Part A.
[21] D. Hutmacher,et al. The return of a forgotten polymer : Polycaprolactone in the 21st century , 2009 .
[22] A. Mikos,et al. The role of lipase and alpha-amylase in the degradation of starch/poly(epsilon-caprolactone) fiber meshes and the osteogenic differentiation of cultured marrow stromal cells. , 2009, Tissue engineering. Part A.
[23] Leda Klouda,et al. Effect of biomimetic conditions on mechanical and structural integrity of PGA/P4HB and electrospun PCL scaffolds , 2008, Journal of materials science. Materials in medicine.
[24] Marcel C M Rutten,et al. Autologous Human Tissue-Engineered Heart Valves: Prospects for Systemic Application , 2006, Circulation.
[25] Frank P T Baaijens,et al. Fibrin as a cell carrier in cardiovascular tissue engineering applications. , 2005, Biomaterials.
[26] Eve Langelier,et al. Tissue reorganization in response to mechanical load increases functionality. , 2005, Tissue engineering.
[27] H. S. Azevedo,et al. Understanding the enzymatic degradation of biodegradable polymers and strategies to control their degradation rate , 2005 .
[28] C. Nicolini,et al. Lipase-catalyzed degradation of poly(ε-caprolactone) , 2004 .
[29] K J Halbhuber,et al. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves. , 2004, Matrix biology : journal of the International Society for Matrix Biology.
[30] Xuesi Chen,et al. Enzymatic degradation of poly(L-lactide) and poly(epsilon-caprolactone) electrospun fibers. , 2004, Macromolecular bioscience.
[31] David P. Martin,et al. Medical applications of poly-4-hydroxybutyrate: a strong flexible absorbable biomaterial , 2003 .
[32] Giulio Gabbiani,et al. Mechanisms of force generation and transmission by myofibroblasts. , 2003, Current opinion in biotechnology.
[33] L. Niklason,et al. Effects of polyglycolic acid on porcine smooth muscle cell growth and differentiation. , 2003, Journal of biomedical materials research. Part A.
[34] R. Adhikari,et al. Biodegradable synthetic polymers for tissue engineering. , 2003, European cells & materials.
[35] F J Schoen,et al. Functional Living Trileaflet Heart Valves Grown In Vitro , 2000, Circulation.
[36] R. Bank,et al. Collagen Structure Regulates Fibril Mineralization in Osteogenesis as Revealed by Cross‐Link Patterns in Calcifying Callus , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[37] R. Bank,et al. Sensitive fluorimetric quantitation of pyridinium and pentosidine crosslinks in biological samples in a single high-performance liquid chromatographic run. , 1997, Journal of chromatography. B, Biomedical sciences and applications.
[38] S P Robins,et al. Standardization of pyridinium crosslinks, pyridinoline and deoxypyridinoline, for use as biochemical markers of collagen degradation. , 1996, Clinical chemistry.
[39] R. Bank,et al. Amino acid analysis by reverse-phase high-performance liquid chromatography: improved derivatization and detection conditions with 9-fluorenylmethyl chloroformate. , 1996, Analytical biochemistry.
[40] N. Tietz,et al. Lipase in serum--the elusive enzyme: an overview. , 1993, Clinical chemistry.
[41] D. Buttle,et al. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. , 1986, Biochimica et biophysica acta.
[42] F. Naftolin,et al. Monitoring of collagen and collagen fragments in chromatography of protein mixtures. , 1980, Analytical biochemistry.
[43] C. Bolognesi,et al. Improved microfluorometric DNA determination in biological material using 33258 Hoechst. , 1979, Analytical biochemistry.